J2KBIO Co., Ltd. (KOSDAQ:420570)
South Korea
· Delayed Price · Currency is KRW 8,310.00
-140.00 (-1.66%)
At close: Apr 28, 2026
J2KBIO Market Cap
J2KBIO has a market cap or net worth of 48.59 billion as of April 29, 2026. Its market cap has decreased by -33.20% in one year.
Market Cap
48.59B
Enterprise Value
37.03B
Revenue
32.97B
Ranking
n/a
PE Ratio
18.10
Stock Price
8,310.00
Market Cap Chart
Since March 25, 2024, J2KBIO's market cap has decreased from 144.93B to 48.59B, a decrease of -66.47%. That is a compound annual growth rate of -40.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 48.59B | -3.37% |
| Dec 30, 2025 | 50.29B | -3.28% |
| Dec 30, 2024 | 52.00B | -64.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ADBiotech | 52.15B |
| Parataxis Korea | 44.13B |
| Poongjeon Pharmacy CO.,LTD. | 40.98B |
| EyeGene | 62.90B |
| MOA Life Plus | 36.69B |
| Kainos Medicine | 35.56B |
| Eutilex.Co.,Ltd | 35.32B |
| HLB Pep | 67.47B |